M, S., H, B., DK, B., DC, W., AS, L., A, G., . . . M, J. (2025). DLL3 Expression in Neuroendocrine Carcinomas and Neuroendocrine Tumours: Insights From a Multicentric Cohort of 1294 Pulmonary and Extrapulmonary Neuroendocrine Neoplasms. Endocrine pathology, 36(1), 9. https://doi.org/10.1007/s12022-025-09854-3
Chicago Style (17th ed.) CitationM, Schmitt, et al. "DLL3 Expression in Neuroendocrine Carcinomas and Neuroendocrine Tumours: Insights From a Multicentric Cohort of 1294 Pulmonary and Extrapulmonary Neuroendocrine Neoplasms." Endocrine Pathology 36, no. 1 (2025): 9. https://doi.org/10.1007/s12022-025-09854-3.
MLA (9th ed.) CitationM, Schmitt, et al. "DLL3 Expression in Neuroendocrine Carcinomas and Neuroendocrine Tumours: Insights From a Multicentric Cohort of 1294 Pulmonary and Extrapulmonary Neuroendocrine Neoplasms." Endocrine Pathology, vol. 36, no. 1, 2025, p. 9, https://doi.org/10.1007/s12022-025-09854-3.